Literature DB >> 23774346

Corticosteroids and acute respiratory distress syndrome: the debate continues.

Patrick Belvitch, Steven M Dudek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774346      PMCID: PMC3703846          DOI: 10.1097/CCM.0b013e3182963cfb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  15 in total

1.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

2.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

3.  Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion.

Authors:  Michelle Ng Gong; B Taylor Thompson; Paige Williams; Lucille Pothier; Paul D Boyce; David C Christiani
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

6.  Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome.

Authors:  R M Schein; R Bergman; E H Marcial; D Schultz; R C Duncan; P I Arnold; C L Sprung
Journal:  Chest       Date:  1987-06       Impact factor: 9.410

Review 7.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.

Authors:  John Victor Peter; Preeta John; Petra L Graham; John L Moran; Ige Abraham George; Andrew Bersten
Journal:  BMJ       Date:  2008-04-23

8.  The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes.

Authors:  Lioudmila V Karnatovskaia; Augustine S Lee; Ognjen Gajic; Emir Festic
Journal:  Crit Care Med       Date:  2013-07       Impact factor: 7.598

9.  Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.

Authors:  J M Luce; A B Montgomery; J D Marks; J Turner; C A Metz; J F Murray
Journal:  Am Rev Respir Dis       Date:  1988-07

10.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

Authors:  G Umberto Meduri; Emmel Golden; Amado X Freire; Edwin Taylor; Muhammad Zaman; Stephanie J Carson; Mary Gibson; Reba Umberger
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

View more
  2 in total

Review 1.  New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome.

Authors:  Chin-Yao Yang; Chien-Sheng Chen; Giou-Teng Yiang; Yeung-Leung Cheng; Su-Boon Yong; Meng-Yu Wu; Chia-Jung Li
Journal:  Int J Mol Sci       Date:  2018-02-16       Impact factor: 5.923

2.  The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients.

Authors:  Lindsay A Ritter; Noel Britton; Emily L Heil; William A Teeter; Sarah B Murthi; Jonathan H Chow; Emily Ricotta; Daniel S Chertow; Alison Grazioli; Andrea R Levine
Journal:  J Intensive Care Med       Date:  2021-07-12       Impact factor: 3.510

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.